NDC 65302-063

Tobramycin Inhalation Solution

Tobramycin

Tobramycin Inhalation Solution is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by The Ritedose Corporation. The primary component is Tobramycin.

Product ID65302-063_f05e4685-c086-90e3-e053-2995a90a5cd8
NDC65302-063
Product TypeHuman Prescription Drug
Proprietary NameTobramycin Inhalation Solution
Generic NameTobramycin
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2014-05-29
Marketing CategoryANDA /
Application NumberANDA201422
Labeler NameThe Ritedose Corporation
Substance NameTOBRAMYCIN
Active Ingredient Strength300 mg/5mL
Pharm ClassesAminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65302-063-04

14 POUCH in 1 CARTON (65302-063-04) > 4 AMPULE in 1 POUCH > 5 mL in 1 AMPULE
Marketing Start Date2014-05-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tobramycin Inhalation Solution" or generic name "Tobramycin"

NDCBrand NameGeneric Name
16714-119Tobramycin Inhalation SolutionTobramycin Inhalation Solution
43598-605Tobramycin Inhalation SolutionTobramycin Inhalation Solution
10122-820BETHKIStobramycin
0078-0494TOBITobramycin
0078-0630TOBI PodhalerTobramycin
0093-3750TobramycinTobramycin
0093-4085TobramycinTobramycin
0404-7196TobramycinTobramycin
0409-3578TOBRAMYCINTOBRAMYCIN
0703-9402TobramycinTobramycin
0781-7171TobramycinTobramycin
10544-883TobramycinTobramycin
13985-604TobramycinTobramycin
13985-743TobramycinTobramycin
17478-290TobramycinTobramycin
0065-0643Tobrextobramycin
0065-0644TOBREXtobramycin
0078-0813TOBREXtobramycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.